Royalty Pharma plc announced on August 13, 2025, that Henry Fernandez, its Lead Independent Director, stepped down from the Board of Directors, effective immediately. Mr. Fernandez had served on the Board since July 2020 and was appointed Lead Independent Director in March 2021.
The company expressed gratitude for Mr. Fernandez's contributions over the past five years, noting his experience as a seasoned chief executive of a public company and his business acumen. His leadership was instrumental in achieving milestones, including the completion of the internalization of the external manager.
Royalty Pharma intends to name a new Lead Independent Director in the near future. The departure marks a change in the company's board leadership structure, following a period of significant strategic evolution for the company.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.